Indraprastha Medical Corporation Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Indraprastha Medical Corporation announced that ICRA has re-affirmed its rating on the long term bank facility and instrument of the company at ?[ICRA]AA(Stable)? and the short term rating at [ICRA]A1+?.

Indraprastha Medical Corporation announced that the Board of Directors of the Company at its meeting held on 12 May 2026, inter alia, have recommended the final dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.

Net profit of Indraprastha Medical Corporation rose 1.68% to Rs 41.70 crore in the quarter ended March 2026 as against Rs 41.01 crore during the previous quarter ended March 2025. Sales rose 9.31% to Rs 364.81 crore in the quarter ended March 2026 as against Rs 333.75 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.06% to Rs 183.62 crore in the year ended March 2026 as against Rs 160.99 crore during the previous year ended March 2025. Sales rose 9.30% to Rs 1482.51 crore in the year ended March 2026 as against Rs 1356.36 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 12 May 2026.